Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

July 2, 2024

Study Completion Date

October 30, 2024

Conditions

Healthy

Interventions

DRUG

[14C]HSK31858

A single oral dose of 40 mg/120 μCi \[14C\]HSK31858 after fasting for at least 10 hours.

Trial Locations (1)

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

Xizang Haisco Pharmaceutical Co., Ltd

INDUSTRY

NCT06569784 - Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects. | Biotech Hunter | Biotech Hunter